Spencer Guthrie

Summary
Spencer Guthrie is a seasoned Strategic Advisor with a strong background in biotech, academia, patient advocacy, and venture capital.
With over 20 years of experience in clinical development across multiple disease indications, Spencer has excelled in roles like Clinical Operations, Project Management, and Project Leadership.
His expertise includes managing cross-functional teams, direct line management, market development, market research, publication strategy, medical education, business development, and thought leader development.
Spencer also has specific experience as an R&D Project Team Leader and a Compound Development Team Lead.
His specialties encompass Global Development Strategy, Clinical Development, Clinical Operations, Medical Affairs, Project Management, US and International regulatory expertise, publication planning, and data monitoring.
Spencer Guthrie holds a Master of Public Health (MPH) from Johns Hopkins Bloomberg School of Public Health, an MBA from the University of California, Irvine - The Paul Merage School of Business, and a Bachelor's degree from Vanderbilt University.
He has held key leadership positions such as Chief Executive Officer at Attralus, President at Biopharma Strategy Consulting, VP at Akcea Therapeutics and Prothena Biosciences, Head of Development Affairs and Operations at Prothena Biosciences, Sr. Director and Head of Clinical Operations at Ultragenyx Pharmaceutical Inc., Director at Janssen Alzheimer Immunotherapy Research and Development, and various roles at Elan Pharmaceuticals, Genentech, and ICON Clinical Research.
Spencer Guthrie's diverse background and extensive expertise make him a valuable asset in the fields of biotech, clinical development, medical affairs, and project leadership.